Methimazole Transdermal

Methimazole Transdermal combines a high-potency antithyroid agent with specialized permeation enhancers to create a therapeutic synergy that ensures effective drug delivery across the stratum corneum. This advanced transdermal route provides a significant clinical benefit by bypassing the gastrointestinal tract, thereby reducing the incidence of adverse metabolic side effects and improving patient adherence in cases where oral administration is challenging. By maintaining steady-state plasma concentrations through continuous percutaneous absorption, this formulation offers a reliable and minimally invasive solution for the long-term management of hyperthyroidism.